Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06213181
Other study ID # -University_of_Jaén
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 19, 2024
Est. completion date April 19, 2024

Study information

Verified date June 2024
Source University of Jaén
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This research corresponds to an experimental study, a randomized controlled clinical trial in people over 65 years of age, distributed into two groups: the experimental group will receive a program that will consist of an eight-week mindfulness-based intervention; and the control group that will only receive general recommendations about the benefits of physical exercise. Measurements will be carried out at the beginning of the intervention and immediately after its completion.


Recruitment information / eligibility

Status Completed
Enrollment 86
Est. completion date April 19, 2024
Est. primary completion date February 26, 2024
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: - The study participants are men and women over 65 years of age residing in the city of JaƩn (Spain). - People with pain with more than 3 months of evolution. - Participants must have completed the informed consent. Exclusion Criteria: - That they do not voluntarily accept to participate in the study and that they are able to understand the instructions and follow the instructions of the intervention.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Mindfulness intervention
It consists of 8 weekly sessions with a duration of 2 hours each. A variety of mindfulness practices including mindful movement will be introduced in all sessions. Participants will approach meditation as something natural and everyday, with the possibility of directing attention in all the moments and activities of daily life. Body scanning practices and conscious breathing will also be included. We will work in the group, with reflections and readings, as well as carrying out meditation and mindfulness practices, during the week, so that they can be carried out in the daily life of each participant. The intervention based on mindfulness will focus on the areas of well-being and personal skills such as attention, communication, emotional regulation and decision making.

Locations

Country Name City State
Spain Municipal social services center "el boulevard" Jaén

Sponsors (1)

Lead Sponsor Collaborator
University of Jaén

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary SF-12 (reduced version of The Health Survey Short Form-36) Used extensively for assessing health-related quality of life. The results are values between 0 and 100. Optimal health is represented by scores of 100 and very poor health would equal 0. Up to twelve weeks
Primary Numeric Rating Scale (NRS) Patients are asked to circle the number between 0 and 10, 0 and 20 or 0 and 100 that fits best to their pain intensity. Zero usually represents 'no pain at all' whereas the upper limit represents 'the worst pain ever possible'. Up to twelve weeks
Primary FSS (Fatigue Severity Scale) A self-report scale describing the severity of fatigue and the impact of fatigue on activities of daily living. The test is made up of 9 items with 7 response possibilities, so that 1 and 7 correspond to the minimum and maximum severity respectively. The total score corresponds to the sum of all the items with a total score range that goes from 9 to 63. Up to twelve weeks
Primary PSQI (Pittsburgh Sleep Quality Index) A simple and valid assessment of both sleep quality and disturbance that might affect. They consist of 10 questions divided into four subscales: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep discomfort, medication use and daytime dysfunctions, adding up to a total score. The higher value represents a worse result. Higher scores indicate poorer sleep. It contains a total of 19 questions, grouped into 10 questions. The 19 questions are combined to form seven areas with their corresponding score, each of which shows a range between 0 and 3 points. In all cases, a score of "0" indicates ease, while a score of 3 indicates severe difficulty, within their respective area. The scores of the seven areas are finally added to give an overall score, which ranges between 0 and 21 points. "0" indicates ease of sleeping and "21" severe difficulty in all areas. Up to twelve weeks
Primary PSS (Perceived Stress Scale) It consists of 14 items with a five-point scale response format (0 = never, 1 = almost never, 2 = occasionally, 3 = often, 4 = very often). The total score of the PSS is obtained by reversing the scores of items 4, 5, 6, 7, 9, 10 and 13 (in the following sense: 0=4, 1=3, 2=2, 3=1 and 4 =0) and then adding the 14 items. The direct score obtained indicates that a higher score corresponds to a higher level of perceived stress. Up to twelve weeks
Primary Chair stand test Evaluate the strength of the lower body. The total number of times you "get up and sit down" in the chair for 30" is counted. If at the end of the exercise the participant has completed half or more of the movement (standing up and sitting down), it will be counted as complete. Up to twelve weeks
Primary TUG test (Timed Up and Go test) Is a simple test used to assess a person's mobility and physical function. Up to twelve weeks
Primary Tinetti scale It is used to determine early the risk of falling in an elderly person during the year following its application. The result of both sections will be added, so that a score of less than 19 points will imply a high risk of falls, a score of 19 to 24 will reflect medium risk of falls and a score of 25 to 28 will indicate low risk of falls. Up to twelve weeks
Primary HADS (The Hospital Anxiety And Depression) A reliable, valid and practical screening tool for identifying and quantifying anxiety and/or depression in non-patients. The test contains 14 items with a score from 0 to 3, of which 7 items refer to depression and 7 to anxiety. The total score is 0-21, where a higher score corresponds to worse symptoms of anxiety and depression. Up to twelve weeks
Primary Arm curl test Evaluate upper body strength. The total number of times the arm is "flexed and extended" during 30" is counted. If at the end of the exercise the participant has completed half or more of the movement (flexion and extension of the arm), it will be counted as complete. Up to twelve weeks
Primary Back scratch test Evaluate the flexibility of the upper body (mainly the shoulders). The participant will make two attempts with the best side before starting the test and it will be noted on the record sheet by putting a circle in the best of them. Up to twelve weeks
Primary Chair-sit and reach-test Evaluate the flexibility of the lower body (mainly biceps femoris). The participant will perform two attempts with the preferred leg and the examiner will record the two results by circling the best of them on the recording sheet. The distance is measured from the tips of the fingers of the hands to the top of the shoe. Touching the toe of the shoe will score "Zero". If the fingers of the hands do not reach the foot, the distance will be measured in negative values (-). If the fingers of the hands exceed the foot, the distance is recorded in positive values (+). Up to twelve weeks
Primary Brief Pain Questionnaire (CBD) It is a multidimensional pain assessment instrument that provides information on the intensity of pain and its interference with patients' daily activities. Also assess the description, location of the pain and the level of relief provided by the treatment. Up to twelve weeks
Secondary BMI (Body Mass Index) Is calculated from the formula, Weight (kg) / Height2 (m2), whose unit is kg/m2. It is a rough indicator of total body fat Up to twelve weeks
Secondary Waist circumference Is used to assess central fat distribution and degree of abdominal obesity Up to twelve weeks
Secondary Hip circumference It is measured at the level of the maximum prominence of the buttocks. Up to twelve weeks
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain